Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chaisson

Showing results (141-150 of 226) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2001
Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responsesT R Sterling, S E Dorman, R E Chaisson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatmentE E Bliven-Sizemore, J L Johnson, S Goldberg, et al.
The New England Journal of Medicine|June 13, 1996
Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxisW R Bishai, N M Graham, S Harrington, et al.
The American Journal of Cardiology|April 15, 1993
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infectionA Herskowitz, D Vlahov, S Willoughby, et al.
Chest|April 1, 1995
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumoniaJ E Gallant, S M McAvinue, R D Moore, et al.
Archives of Internal Medicine|May 1, 1991
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study GroupR D Moore, T Creagh-Kirk, J Keruly, et al.
The American Review of Respiratory Disease|September 1, 1987
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survivalR E Chaisson, G F Schecter, C P Theuer, et al.
JAMA|November 20, 1991
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study GroupP J Easterbrook, J C Keruly, T Creagh-Kirk, et al.
AIDS (London, England)|February 1, 1991
Racial heterogeneity of HIV antigenemia in people with HIV infectionR E Chaisson, E Fuchs, D L Stanton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2006
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factorsT R Sterling, Z Zhao, A Khan, et al.
Pageof 23

Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2001
Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responsesT R Sterling, S E Dorman, R E Chaisson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatmentE E Bliven-Sizemore, J L Johnson, S Goldberg, et al.
The New England Journal of Medicine|June 13, 1996
Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxisW R Bishai, N M Graham, S Harrington, et al.
The American Journal of Cardiology|April 15, 1993
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infectionA Herskowitz, D Vlahov, S Willoughby, et al.
Chest|April 1, 1995
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumoniaJ E Gallant, S M McAvinue, R D Moore, et al.
Archives of Internal Medicine|May 1, 1991
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study GroupR D Moore, T Creagh-Kirk, J Keruly, et al.
The American Review of Respiratory Disease|September 1, 1987
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survivalR E Chaisson, G F Schecter, C P Theuer, et al.
JAMA|November 20, 1991
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study GroupP J Easterbrook, J C Keruly, T Creagh-Kirk, et al.
AIDS (London, England)|February 1, 1991
Racial heterogeneity of HIV antigenemia in people with HIV infectionR E Chaisson, E Fuchs, D L Stanton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2006
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factorsT R Sterling, Z Zhao, A Khan, et al.
Pageof 23